Quantanosis.ai

Who We Are

Quantanosis was founded with the goal to save the life of every stroke patient across the globe using portable, non-invasive, operator-independent robotic histotripsy devices and AI driven software:

    • Founded in 2020
    • Device combines diagnostic imaging and automated histotripsy therapy
    • Efficacy and safety has been tested in animals.
    • FIM expected to start first half of 2026
    • Being developed at Jacobs Institute
    • Funded by $4M SAFE from 30+ world leading stroke experts
    • Seeking $15-20M to run first in man IDE, continue development and pursue pivotal trial.
image

Experienced Founders

Led by proven founders with deep expertise in medtech, AI, and startup growth.

image

Strong Partnerships

Backed by strong partnerships with leading hospitals, research centers, and industry experts to accelerate impact and scale.

image

Raised $4M+ Funds

Raised over $4M from 30+ leading Stroke Experts to fuel innovation, clinical validation, and market expansion

image

Seeking $15-20M

Seeking $15–20M to launch First-in-Man IDE, advance development, and execute a pivotal clinical trial.

Presentations

Quantanosis was showcased and presented at major international events:

 

    • SVIN Annual Meeting November 2024
  •  
    • ESOC in Switzerland May 2024
  •  
    • BRAIN Meeting in London December 2024
  •  
    • ABCwin in Val D'isere January 2025
  •  
    • International Stroke Conference 2025
  •  
    • ICure Istanbul in April 2025
  •  
    • WLNC in Shanghai in 2025
  •  
    • Jackson hole June 2025

 

Built by clinically and operationally experienced founders

Meet Dr. Ameer Hassan

shop-now

Click above to open the article, or play the video.

Preeminent Industry And Academic Partners